Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.86 AED | -.--% | +10.02% | +10.00% |
Valuation
Fiscal Period: December | 2023 |
---|---|
Capitalization 1 | 29,650 |
Enterprise Value (EV) 2 | 29,572 |
P/E ratio | 613 x |
Yield | - |
Capitalization / Revenue | - |
EV / Revenue | - |
EV / EBITDA | -2,070,546,471 x |
EV / FCF | -53,366,879 x |
FCF Yield | -0% |
Price to Book | 4.02 x |
Nbr of stocks (in thousands) | 2,750,000 |
Reference price 3 | 10.78 |
Announcement Date | 3/13/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2022 | 2023 |
---|---|---|
Net sales | - | - |
EBITDA | - | -14.28 |
EBIT 1 | -1.386 | -14.29 |
Operating Margin | - | - |
Earnings before Tax (EBT) 1 | -1.386 | 518.8 |
Net income 1 | -1.386 | 518.8 |
Net margin | - | - |
EPS | - | 0.0176 |
Free Cash Flow | - | -554.1 |
FCF margin | - | - |
FCF Conversion (EBITDA) | - | - |
FCF Conversion (Net income) | - | - |
Dividend per Share | - | - |
Announcement Date | 4/13/23 | 3/13/24 |
Balance Sheet Analysis
Fiscal Period: December | 2022 | 2023 |
---|---|---|
Net Debt 1 | - | - |
Net Cash position 1 | 7.58 | 78.1 |
Leverage (Debt/EBITDA) | - | - |
Free Cash Flow | - | -554 |
ROE (net income / shareholders' equity) | - | 7.62% |
ROA (Net income/ Total Assets) | - | -0.13% |
Assets 1 | - | -399,380 |
Book Value Per Share 2 | 309.0 | 2.680 |
Cash Flow per Share 2 | 1.390 | 0.0300 |
Capex 1 | 0 | 1.12 |
Capex / Sales | - | - |
Announcement Date | 4/13/23 | 3/13/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- MBME Stock
- Financials MBME GROUP Private